Malta - English - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - thiopental sodium - powder for solution for injection - thiopental sodium 500 mg - anesthetics

Malta - English - Medicines Authority

panpharma z.i. du clairay, 35133 luitre, france - thiopental sodium - powder for solution for injection - thiopental sodium 1000 mg - anesthetics

Ireland - English - HPRA (Health Products Regulatory Authority)

panpharma - gentamicin sulfate - solution for injection/infusion - 40 milligram(s)/millilitre - other aminoglycosides; gentamicin

Zimbabwe - English - Medicines Control Authority

panpharma gmbh - heparin sodium - solution; injection - 5000 iu/ml

Zimbabwe - English - Medicines Control Authority

panpharma gmbh - oxytocin - solution; injection - 10 iu/ml

Zimbabwe - English - Medicines Control Authority

panpharma gmbh - phytonadione - solution; injection - 10 mg/ml

Israel - English - Ministry of Health

pharmalogic ltd - ceftriaxone as sodium - powder for solution for inj/inf - ceftriaxone as sodium 1 g/vial - ceftriaxone - ceftriaxone - ceftriaxone panpharma is indicated for the treatment of the following infections in adults and children including term neonates (from birth):- bacterial meningitis- community acquired pneumonia- hospital acquired pneumonia- acute otitis media- intra-abdominal infections- complicated urinary tract infections (including pyelonephritis)- infections of bones and joints- complicated skin and soft tissue infections- gonorrhoea- syphilis- bacterial endocarditisceftriaxone panpharma may be used:- for treatment of acute exacerbations of chronic obstructive pulmonary disease in adults- for treatment of disseminated lyme borreliosis (early (stage ii) and late (stage iii) in adults and children including neonates from 15 days of age.- for pre-operative prophylaxis of surgical site infections- in the management of neutropenic patients with fever that is suspected to be due to a ceftriaxone- susceptible bacterial infection- in the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above ceftriaxone panpharma should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum.consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Israel - English - Ministry of Health

pharmalogic ltd - hydrocortisone as sodium succinate - powder for solution for injection - hydrocortisone as sodium succinate 100 mg/dose - hydrocortisone panpharma is indicated to treat any condition in which im or iv corticosteroid treatment is required such as: - allergic states, - dermatologic diseases, - endocrine disorders, - gastrointestinal diseases,- hematologic disorders, - neoplastic diseases, - nervous system disorders, - ophthalmic diseases, - renal diseases, - respiratory diseases, - rheumatic disorders,- certain medical emergencies.

Israel - English - Ministry of Health

pharmalogic ltd - ketamine as hydrochloride - solution for injection / infusion - ketamine as hydrochloride 50 mg / 1 ml - ketamine - as the sole anaesthetic agent for diagnostic and surgical procedures. when used by intravenous or intramuscular injection, ketamin is best suited for short procedures. with additional doses, or by intravenous infusion, ketamin can be used for longer procedures. if skeletal muscle relaxation is desired a muscle relaxant should be used and respiration should be supported. for the induction of anaesthesia prior to the administration of other general anaesthetic agents. to supplement other anaesthetic agents. specific areas of application or types of procedure: when the intramuscular route of administration is preferred. debridement, painful dressings and skin grafting in burned patients as well as other superficial surgical procedures. neurodiagnostic procedures such as pneumoencephalograms, ventriculograms, myelograms and lumbar punctures. diagnostic and operative procedures of the eye, ear, nose and mouth including dental extractions. (note: eye movement may persist during ophthalmological procedures). anaesthesia in poor-risk patients with depression of vital functions or where depression of vital functions must be avoided if at all possible. orthopaedic procedures such as closed reduction, manipulation femoral pinning, amputations and biopsies. sigmoidoscopy and minor surgery of the anus and rectum, circumcision and pilonidal sinus. cardiac catheterization procedures. caesarian section: as an induction agent in the absence of elevated blood pressure. anaesthesia in the asthmatic patient, either to minimise the risk of an attack of bronchospasm developing or in the presence of bronchospasm

Israel - English - Ministry of Health

pharmalogic ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 1 g - ceftazidime - ceftazidime panpharma is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia- broncho-pulmonary infections in cystic fibrosis- bacterial meningitis- chronic supportive otitis media- malignant otitis externa- complicated urinary tract infections- complicated skin and soft issues infections- complicated intra-abdominal infections- bone and joint infections- peritonitis associated with dialysis in patients with capdtreatment of patients with bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing transurethral resection of the prostate (turp).